Global Rapid Tests

Rapid Tests Comprehensive Study by Type (Over-the-counter (OTC) Rapid Test Product, Professional Rapid Test Product), Application (Infectious Disease, Cardiology, Oncology, Pregnancy and Fertility, Toxicology, Glucose Monitoring, Others), (), Technology (PCR-based, Immunoassay-based, Chromatography-based, Spectroscopy-based), Food Tested (Meat & seafood products, Dairy & dairy products, Processed foods, Fruits & vegetables, Cereals & grains, Nuts, seeds, and spices, Crops, Others), Contaminant (Pathogens, Meat speciation, GMOs, Allergens, Pesticides, Mycotoxins, Heavy metals, Others) Players and Region - Global Market Outlook to 2030

Rapid Tests Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Rapid TestsMarket?
The global market for rapid tests has been rising on account of the popularity of preliminary screening across medical facilities. Rapid tests refer to tests that can be used during emergencies at medical facilities or for home-care treatments. The most unique characteristic of this form of testing is the limited use of resources and the simplicity of execution. The stability of rapid tests at high temperatures coupled with the short span of execution for these tests has given an impetus to the growth of the global market.

Rapid Tests Market Report Coverage
Report CoverageDetails
Study Timeframe2018 to 2030
Base Year2023
Growth Drivers
  • Increasing Popularity of Preliminary Screening across Medical Facilities
  • High Incidence of Infectious Diseases
Challenges & Pitfalls
  • High Cost Associated With Technologies


Opportunities
Increasing Diagnostic Tests across Various Domains within Healthcare and Rising Demand for Faster and Quantitative Assessment Results to Confirm Food Safety

Restraints
  • Lack of Food Control Infrastructure & Resources in Developing Countries
  • Complexity in Testing Techniques


The Players Covered in the Study are:
Akers Biosciences, Inc. (United States), Abbott Laboratories (United States), Becton, Dickinson and Company (United States), Bio-rad Laboratories, Inc. (United States), Cepheid, Inc. (United States), Hologic Inc. (United States), Meridian Bioscience, Inc. (United States), OraSure Technologies, Inc. (United States), Quidel Corporation (United States) and F. Hoffman La Roche, Ltd. (Switzerland)



Market Development Activities
In December 2020, Innova Medical Group, Inc. (IMG), the world's largest manufacturer of rapid antigen test kits, acquired California-based Biological Laboratory Inc. (BIOLAB), further strengthening IMG's in-house diagnostic testing and research and development capability in the U.S.

In April 2020, Affinity Health Partners announced the introduction of a point-of-care COVID-19 test to its production facilities and network partner’s facilities and is being offered in compliance with the Policy for Coronavirus (COVID-19) Disease Testing designed by the FDA.

Report Objectives / Segmentation Covered

By Type
  • Over-the-counter (OTC) Rapid Test Product
  • Professional Rapid Test Product
By Application
  • Infectious Disease
  • Cardiology
  • Oncology
  • Pregnancy and Fertility
  • Toxicology
  • Glucose Monitoring
  • Others
By Technology
  • PCR-based
  • Immunoassay-based
  • Chromatography-based
  • Spectroscopy-based

By Food Tested
  • Meat & seafood products
  • Dairy & dairy products
  • Processed foods
  • Fruits & vegetables
  • Cereals & grains
  • Nuts, seeds, and spices
  • Crops
  • Others

By Contaminant
  • Pathogens
  • Meat speciation
  • GMOs
  • Allergens
  • Pesticides
  • Mycotoxins
  • Heavy metals
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Popularity of Preliminary Screening across Medical Facilities
      • 3.2.2. High Incidence of Infectious Diseases
    • 3.3. Market Challenges
      • 3.3.1. High Cost Associated With Technologies
    • 3.4. Market Trends
      • 3.4.1. Surge in R&D Activities
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Rapid Tests, by Type, Application, , Technology, Food Tested, Contaminant and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Rapid Tests (Value)
      • 5.2.1. Global Rapid Tests by: Type (Value)
        • 5.2.1.1. Over-the-counter (OTC) Rapid Test Product
        • 5.2.1.2. Professional Rapid Test Product
      • 5.2.2. Global Rapid Tests by: Application (Value)
        • 5.2.2.1. Infectious Disease
        • 5.2.2.2. Cardiology
        • 5.2.2.3. Oncology
        • 5.2.2.4. Pregnancy and Fertility
        • 5.2.2.5. Toxicology
        • 5.2.2.6. Glucose Monitoring
        • 5.2.2.7. Others
      • 5.2.3. Global Rapid Tests by: Technology (Value)
        • 5.2.3.1. PCR-based
        • 5.2.3.2. Immunoassay-based
        • 5.2.3.3. Chromatography-based
        • 5.2.3.4. Spectroscopy-based
      • 5.2.4. Global Rapid Tests by: Food Tested (Value)
        • 5.2.4.1. Meat & seafood products
        • 5.2.4.2. Dairy & dairy products
        • 5.2.4.3. Processed foods
        • 5.2.4.4. Fruits & vegetables
        • 5.2.4.5. Cereals & grains
        • 5.2.4.6. Nuts, seeds, and spices
        • 5.2.4.7. Crops
        • 5.2.4.8. Others
      • 5.2.5. Global Rapid Tests by: Contaminant (Value)
        • 5.2.5.1. Pathogens
        • 5.2.5.2. Meat speciation
        • 5.2.5.3. GMOs
        • 5.2.5.4. Allergens
        • 5.2.5.5. Pesticides
        • 5.2.5.6. Mycotoxins
        • 5.2.5.7. Heavy metals
        • 5.2.5.8. Others
      • 5.2.6. Global Rapid Tests Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Rapid Tests (Price)
      • 5.3.1. Global Rapid Tests by: Type (Price)
  • 6. Rapid Tests: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Akers Biosciences, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Abbott Laboratories (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Becton, Dickinson and Company (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Bio-rad Laboratories, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Cepheid, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Hologic Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Meridian Bioscience, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. OraSure Technologies, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Quidel Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. F. Hoffman La Roche, Ltd. (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Rapid Tests Sale, by Type, Application, , Technology, Food Tested, Contaminant and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Rapid Tests (Value)
      • 7.2.1. Global Rapid Tests by: Type (Value)
        • 7.2.1.1. Over-the-counter (OTC) Rapid Test Product
        • 7.2.1.2. Professional Rapid Test Product
      • 7.2.2. Global Rapid Tests by: Application (Value)
        • 7.2.2.1. Infectious Disease
        • 7.2.2.2. Cardiology
        • 7.2.2.3. Oncology
        • 7.2.2.4. Pregnancy and Fertility
        • 7.2.2.5. Toxicology
        • 7.2.2.6. Glucose Monitoring
        • 7.2.2.7. Others
      • 7.2.3. Global Rapid Tests by: Technology (Value)
        • 7.2.3.1. PCR-based
        • 7.2.3.2. Immunoassay-based
        • 7.2.3.3. Chromatography-based
        • 7.2.3.4. Spectroscopy-based
      • 7.2.4. Global Rapid Tests by: Food Tested (Value)
        • 7.2.4.1. Meat & seafood products
        • 7.2.4.2. Dairy & dairy products
        • 7.2.4.3. Processed foods
        • 7.2.4.4. Fruits & vegetables
        • 7.2.4.5. Cereals & grains
        • 7.2.4.6. Nuts, seeds, and spices
        • 7.2.4.7. Crops
        • 7.2.4.8. Others
      • 7.2.5. Global Rapid Tests by: Contaminant (Value)
        • 7.2.5.1. Pathogens
        • 7.2.5.2. Meat speciation
        • 7.2.5.3. GMOs
        • 7.2.5.4. Allergens
        • 7.2.5.5. Pesticides
        • 7.2.5.6. Mycotoxins
        • 7.2.5.7. Heavy metals
        • 7.2.5.8. Others
      • 7.2.6. Global Rapid Tests Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Rapid Tests (Price)
      • 7.3.1. Global Rapid Tests by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Rapid Tests: by Type(USD Million)
  • Table 2. Rapid Tests Over-the-counter (OTC) Rapid Test Product , by Region USD Million (2018-2023)
  • Table 3. Rapid Tests Professional Rapid Test Product , by Region USD Million (2018-2023)
  • Table 4. Rapid Tests: by Application(USD Million)
  • Table 5. Rapid Tests Infectious Disease , by Region USD Million (2018-2023)
  • Table 6. Rapid Tests Cardiology , by Region USD Million (2018-2023)
  • Table 7. Rapid Tests Oncology , by Region USD Million (2018-2023)
  • Table 8. Rapid Tests Pregnancy and Fertility , by Region USD Million (2018-2023)
  • Table 9. Rapid Tests Toxicology , by Region USD Million (2018-2023)
  • Table 10. Rapid Tests Glucose Monitoring , by Region USD Million (2018-2023)
  • Table 11. Rapid Tests Others , by Region USD Million (2018-2023)
  • Table 12. Rapid Tests: by Technology(USD Million)
  • Table 13. Rapid Tests PCR-based , by Region USD Million (2018-2023)
  • Table 14. Rapid Tests Immunoassay-based , by Region USD Million (2018-2023)
  • Table 15. Rapid Tests Chromatography-based , by Region USD Million (2018-2023)
  • Table 16. Rapid Tests Spectroscopy-based , by Region USD Million (2018-2023)
  • Table 17. Rapid Tests: by Food Tested(USD Million)
  • Table 18. Rapid Tests Meat & seafood products , by Region USD Million (2018-2023)
  • Table 19. Rapid Tests Dairy & dairy products , by Region USD Million (2018-2023)
  • Table 20. Rapid Tests Processed foods , by Region USD Million (2018-2023)
  • Table 21. Rapid Tests Fruits & vegetables , by Region USD Million (2018-2023)
  • Table 22. Rapid Tests Cereals & grains , by Region USD Million (2018-2023)
  • Table 23. Rapid Tests Nuts, seeds, and spices , by Region USD Million (2018-2023)
  • Table 24. Rapid Tests Crops , by Region USD Million (2018-2023)
  • Table 25. Rapid Tests Others , by Region USD Million (2018-2023)
  • Table 26. Rapid Tests: by Contaminant(USD Million)
  • Table 27. Rapid Tests Pathogens , by Region USD Million (2018-2023)
  • Table 28. Rapid Tests Meat speciation , by Region USD Million (2018-2023)
  • Table 29. Rapid Tests GMOs , by Region USD Million (2018-2023)
  • Table 30. Rapid Tests Allergens , by Region USD Million (2018-2023)
  • Table 31. Rapid Tests Pesticides , by Region USD Million (2018-2023)
  • Table 32. Rapid Tests Mycotoxins , by Region USD Million (2018-2023)
  • Table 33. Rapid Tests Heavy metals , by Region USD Million (2018-2023)
  • Table 34. Rapid Tests Others , by Region USD Million (2018-2023)
  • Table 35. South America Rapid Tests, by Country USD Million (2018-2023)
  • Table 36. South America Rapid Tests, by Type USD Million (2018-2023)
  • Table 37. South America Rapid Tests, by Application USD Million (2018-2023)
  • Table 38. South America Rapid Tests, by Technology USD Million (2018-2023)
  • Table 39. South America Rapid Tests, by Food Tested USD Million (2018-2023)
  • Table 40. South America Rapid Tests, by Contaminant USD Million (2018-2023)
  • Table 41. Brazil Rapid Tests, by Type USD Million (2018-2023)
  • Table 42. Brazil Rapid Tests, by Application USD Million (2018-2023)
  • Table 43. Brazil Rapid Tests, by Technology USD Million (2018-2023)
  • Table 44. Brazil Rapid Tests, by Food Tested USD Million (2018-2023)
  • Table 45. Brazil Rapid Tests, by Contaminant USD Million (2018-2023)
  • Table 46. Argentina Rapid Tests, by Type USD Million (2018-2023)
  • Table 47. Argentina Rapid Tests, by Application USD Million (2018-2023)
  • Table 48. Argentina Rapid Tests, by Technology USD Million (2018-2023)
  • Table 49. Argentina Rapid Tests, by Food Tested USD Million (2018-2023)
  • Table 50. Argentina Rapid Tests, by Contaminant USD Million (2018-2023)
  • Table 51. Rest of South America Rapid Tests, by Type USD Million (2018-2023)
  • Table 52. Rest of South America Rapid Tests, by Application USD Million (2018-2023)
  • Table 53. Rest of South America Rapid Tests, by Technology USD Million (2018-2023)
  • Table 54. Rest of South America Rapid Tests, by Food Tested USD Million (2018-2023)
  • Table 55. Rest of South America Rapid Tests, by Contaminant USD Million (2018-2023)
  • Table 56. Asia Pacific Rapid Tests, by Country USD Million (2018-2023)
  • Table 57. Asia Pacific Rapid Tests, by Type USD Million (2018-2023)
  • Table 58. Asia Pacific Rapid Tests, by Application USD Million (2018-2023)
  • Table 59. Asia Pacific Rapid Tests, by Technology USD Million (2018-2023)
  • Table 60. Asia Pacific Rapid Tests, by Food Tested USD Million (2018-2023)
  • Table 61. Asia Pacific Rapid Tests, by Contaminant USD Million (2018-2023)
  • Table 62. China Rapid Tests, by Type USD Million (2018-2023)
  • Table 63. China Rapid Tests, by Application USD Million (2018-2023)
  • Table 64. China Rapid Tests, by Technology USD Million (2018-2023)
  • Table 65. China Rapid Tests, by Food Tested USD Million (2018-2023)
  • Table 66. China Rapid Tests, by Contaminant USD Million (2018-2023)
  • Table 67. Japan Rapid Tests, by Type USD Million (2018-2023)
  • Table 68. Japan Rapid Tests, by Application USD Million (2018-2023)
  • Table 69. Japan Rapid Tests, by Technology USD Million (2018-2023)
  • Table 70. Japan Rapid Tests, by Food Tested USD Million (2018-2023)
  • Table 71. Japan Rapid Tests, by Contaminant USD Million (2018-2023)
  • Table 72. India Rapid Tests, by Type USD Million (2018-2023)
  • Table 73. India Rapid Tests, by Application USD Million (2018-2023)
  • Table 74. India Rapid Tests, by Technology USD Million (2018-2023)
  • Table 75. India Rapid Tests, by Food Tested USD Million (2018-2023)
  • Table 76. India Rapid Tests, by Contaminant USD Million (2018-2023)
  • Table 77. South Korea Rapid Tests, by Type USD Million (2018-2023)
  • Table 78. South Korea Rapid Tests, by Application USD Million (2018-2023)
  • Table 79. South Korea Rapid Tests, by Technology USD Million (2018-2023)
  • Table 80. South Korea Rapid Tests, by Food Tested USD Million (2018-2023)
  • Table 81. South Korea Rapid Tests, by Contaminant USD Million (2018-2023)
  • Table 82. Taiwan Rapid Tests, by Type USD Million (2018-2023)
  • Table 83. Taiwan Rapid Tests, by Application USD Million (2018-2023)
  • Table 84. Taiwan Rapid Tests, by Technology USD Million (2018-2023)
  • Table 85. Taiwan Rapid Tests, by Food Tested USD Million (2018-2023)
  • Table 86. Taiwan Rapid Tests, by Contaminant USD Million (2018-2023)
  • Table 87. Australia Rapid Tests, by Type USD Million (2018-2023)
  • Table 88. Australia Rapid Tests, by Application USD Million (2018-2023)
  • Table 89. Australia Rapid Tests, by Technology USD Million (2018-2023)
  • Table 90. Australia Rapid Tests, by Food Tested USD Million (2018-2023)
  • Table 91. Australia Rapid Tests, by Contaminant USD Million (2018-2023)
  • Table 92. Rest of Asia-Pacific Rapid Tests, by Type USD Million (2018-2023)
  • Table 93. Rest of Asia-Pacific Rapid Tests, by Application USD Million (2018-2023)
  • Table 94. Rest of Asia-Pacific Rapid Tests, by Technology USD Million (2018-2023)
  • Table 95. Rest of Asia-Pacific Rapid Tests, by Food Tested USD Million (2018-2023)
  • Table 96. Rest of Asia-Pacific Rapid Tests, by Contaminant USD Million (2018-2023)
  • Table 97. Europe Rapid Tests, by Country USD Million (2018-2023)
  • Table 98. Europe Rapid Tests, by Type USD Million (2018-2023)
  • Table 99. Europe Rapid Tests, by Application USD Million (2018-2023)
  • Table 100. Europe Rapid Tests, by Technology USD Million (2018-2023)
  • Table 101. Europe Rapid Tests, by Food Tested USD Million (2018-2023)
  • Table 102. Europe Rapid Tests, by Contaminant USD Million (2018-2023)
  • Table 103. Germany Rapid Tests, by Type USD Million (2018-2023)
  • Table 104. Germany Rapid Tests, by Application USD Million (2018-2023)
  • Table 105. Germany Rapid Tests, by Technology USD Million (2018-2023)
  • Table 106. Germany Rapid Tests, by Food Tested USD Million (2018-2023)
  • Table 107. Germany Rapid Tests, by Contaminant USD Million (2018-2023)
  • Table 108. France Rapid Tests, by Type USD Million (2018-2023)
  • Table 109. France Rapid Tests, by Application USD Million (2018-2023)
  • Table 110. France Rapid Tests, by Technology USD Million (2018-2023)
  • Table 111. France Rapid Tests, by Food Tested USD Million (2018-2023)
  • Table 112. France Rapid Tests, by Contaminant USD Million (2018-2023)
  • Table 113. Italy Rapid Tests, by Type USD Million (2018-2023)
  • Table 114. Italy Rapid Tests, by Application USD Million (2018-2023)
  • Table 115. Italy Rapid Tests, by Technology USD Million (2018-2023)
  • Table 116. Italy Rapid Tests, by Food Tested USD Million (2018-2023)
  • Table 117. Italy Rapid Tests, by Contaminant USD Million (2018-2023)
  • Table 118. United Kingdom Rapid Tests, by Type USD Million (2018-2023)
  • Table 119. United Kingdom Rapid Tests, by Application USD Million (2018-2023)
  • Table 120. United Kingdom Rapid Tests, by Technology USD Million (2018-2023)
  • Table 121. United Kingdom Rapid Tests, by Food Tested USD Million (2018-2023)
  • Table 122. United Kingdom Rapid Tests, by Contaminant USD Million (2018-2023)
  • Table 123. Netherlands Rapid Tests, by Type USD Million (2018-2023)
  • Table 124. Netherlands Rapid Tests, by Application USD Million (2018-2023)
  • Table 125. Netherlands Rapid Tests, by Technology USD Million (2018-2023)
  • Table 126. Netherlands Rapid Tests, by Food Tested USD Million (2018-2023)
  • Table 127. Netherlands Rapid Tests, by Contaminant USD Million (2018-2023)
  • Table 128. Rest of Europe Rapid Tests, by Type USD Million (2018-2023)
  • Table 129. Rest of Europe Rapid Tests, by Application USD Million (2018-2023)
  • Table 130. Rest of Europe Rapid Tests, by Technology USD Million (2018-2023)
  • Table 131. Rest of Europe Rapid Tests, by Food Tested USD Million (2018-2023)
  • Table 132. Rest of Europe Rapid Tests, by Contaminant USD Million (2018-2023)
  • Table 133. MEA Rapid Tests, by Country USD Million (2018-2023)
  • Table 134. MEA Rapid Tests, by Type USD Million (2018-2023)
  • Table 135. MEA Rapid Tests, by Application USD Million (2018-2023)
  • Table 136. MEA Rapid Tests, by Technology USD Million (2018-2023)
  • Table 137. MEA Rapid Tests, by Food Tested USD Million (2018-2023)
  • Table 138. MEA Rapid Tests, by Contaminant USD Million (2018-2023)
  • Table 139. Middle East Rapid Tests, by Type USD Million (2018-2023)
  • Table 140. Middle East Rapid Tests, by Application USD Million (2018-2023)
  • Table 141. Middle East Rapid Tests, by Technology USD Million (2018-2023)
  • Table 142. Middle East Rapid Tests, by Food Tested USD Million (2018-2023)
  • Table 143. Middle East Rapid Tests, by Contaminant USD Million (2018-2023)
  • Table 144. Africa Rapid Tests, by Type USD Million (2018-2023)
  • Table 145. Africa Rapid Tests, by Application USD Million (2018-2023)
  • Table 146. Africa Rapid Tests, by Technology USD Million (2018-2023)
  • Table 147. Africa Rapid Tests, by Food Tested USD Million (2018-2023)
  • Table 148. Africa Rapid Tests, by Contaminant USD Million (2018-2023)
  • Table 149. North America Rapid Tests, by Country USD Million (2018-2023)
  • Table 150. North America Rapid Tests, by Type USD Million (2018-2023)
  • Table 151. North America Rapid Tests, by Application USD Million (2018-2023)
  • Table 152. North America Rapid Tests, by Technology USD Million (2018-2023)
  • Table 153. North America Rapid Tests, by Food Tested USD Million (2018-2023)
  • Table 154. North America Rapid Tests, by Contaminant USD Million (2018-2023)
  • Table 155. United States Rapid Tests, by Type USD Million (2018-2023)
  • Table 156. United States Rapid Tests, by Application USD Million (2018-2023)
  • Table 157. United States Rapid Tests, by Technology USD Million (2018-2023)
  • Table 158. United States Rapid Tests, by Food Tested USD Million (2018-2023)
  • Table 159. United States Rapid Tests, by Contaminant USD Million (2018-2023)
  • Table 160. Canada Rapid Tests, by Type USD Million (2018-2023)
  • Table 161. Canada Rapid Tests, by Application USD Million (2018-2023)
  • Table 162. Canada Rapid Tests, by Technology USD Million (2018-2023)
  • Table 163. Canada Rapid Tests, by Food Tested USD Million (2018-2023)
  • Table 164. Canada Rapid Tests, by Contaminant USD Million (2018-2023)
  • Table 165. Mexico Rapid Tests, by Type USD Million (2018-2023)
  • Table 166. Mexico Rapid Tests, by Application USD Million (2018-2023)
  • Table 167. Mexico Rapid Tests, by Technology USD Million (2018-2023)
  • Table 168. Mexico Rapid Tests, by Food Tested USD Million (2018-2023)
  • Table 169. Mexico Rapid Tests, by Contaminant USD Million (2018-2023)
  • Table 170. Rapid Tests: by Type(USD/Units)
  • Table 171. Company Basic Information, Sales Area and Its Competitors
  • Table 172. Company Basic Information, Sales Area and Its Competitors
  • Table 173. Company Basic Information, Sales Area and Its Competitors
  • Table 174. Company Basic Information, Sales Area and Its Competitors
  • Table 175. Company Basic Information, Sales Area and Its Competitors
  • Table 176. Company Basic Information, Sales Area and Its Competitors
  • Table 177. Company Basic Information, Sales Area and Its Competitors
  • Table 178. Company Basic Information, Sales Area and Its Competitors
  • Table 179. Company Basic Information, Sales Area and Its Competitors
  • Table 180. Company Basic Information, Sales Area and Its Competitors
  • Table 181. Rapid Tests: by Type(USD Million)
  • Table 182. Rapid Tests Over-the-counter (OTC) Rapid Test Product , by Region USD Million (2025-2030)
  • Table 183. Rapid Tests Professional Rapid Test Product , by Region USD Million (2025-2030)
  • Table 184. Rapid Tests: by Application(USD Million)
  • Table 185. Rapid Tests Infectious Disease , by Region USD Million (2025-2030)
  • Table 186. Rapid Tests Cardiology , by Region USD Million (2025-2030)
  • Table 187. Rapid Tests Oncology , by Region USD Million (2025-2030)
  • Table 188. Rapid Tests Pregnancy and Fertility , by Region USD Million (2025-2030)
  • Table 189. Rapid Tests Toxicology , by Region USD Million (2025-2030)
  • Table 190. Rapid Tests Glucose Monitoring , by Region USD Million (2025-2030)
  • Table 191. Rapid Tests Others , by Region USD Million (2025-2030)
  • Table 192. Rapid Tests: by Technology(USD Million)
  • Table 193. Rapid Tests PCR-based , by Region USD Million (2025-2030)
  • Table 194. Rapid Tests Immunoassay-based , by Region USD Million (2025-2030)
  • Table 195. Rapid Tests Chromatography-based , by Region USD Million (2025-2030)
  • Table 196. Rapid Tests Spectroscopy-based , by Region USD Million (2025-2030)
  • Table 197. Rapid Tests: by Food Tested(USD Million)
  • Table 198. Rapid Tests Meat & seafood products , by Region USD Million (2025-2030)
  • Table 199. Rapid Tests Dairy & dairy products , by Region USD Million (2025-2030)
  • Table 200. Rapid Tests Processed foods , by Region USD Million (2025-2030)
  • Table 201. Rapid Tests Fruits & vegetables , by Region USD Million (2025-2030)
  • Table 202. Rapid Tests Cereals & grains , by Region USD Million (2025-2030)
  • Table 203. Rapid Tests Nuts, seeds, and spices , by Region USD Million (2025-2030)
  • Table 204. Rapid Tests Crops , by Region USD Million (2025-2030)
  • Table 205. Rapid Tests Others , by Region USD Million (2025-2030)
  • Table 206. Rapid Tests: by Contaminant(USD Million)
  • Table 207. Rapid Tests Pathogens , by Region USD Million (2025-2030)
  • Table 208. Rapid Tests Meat speciation , by Region USD Million (2025-2030)
  • Table 209. Rapid Tests GMOs , by Region USD Million (2025-2030)
  • Table 210. Rapid Tests Allergens , by Region USD Million (2025-2030)
  • Table 211. Rapid Tests Pesticides , by Region USD Million (2025-2030)
  • Table 212. Rapid Tests Mycotoxins , by Region USD Million (2025-2030)
  • Table 213. Rapid Tests Heavy metals , by Region USD Million (2025-2030)
  • Table 214. Rapid Tests Others , by Region USD Million (2025-2030)
  • Table 215. South America Rapid Tests, by Country USD Million (2025-2030)
  • Table 216. South America Rapid Tests, by Type USD Million (2025-2030)
  • Table 217. South America Rapid Tests, by Application USD Million (2025-2030)
  • Table 218. South America Rapid Tests, by Technology USD Million (2025-2030)
  • Table 219. South America Rapid Tests, by Food Tested USD Million (2025-2030)
  • Table 220. South America Rapid Tests, by Contaminant USD Million (2025-2030)
  • Table 221. Brazil Rapid Tests, by Type USD Million (2025-2030)
  • Table 222. Brazil Rapid Tests, by Application USD Million (2025-2030)
  • Table 223. Brazil Rapid Tests, by Technology USD Million (2025-2030)
  • Table 224. Brazil Rapid Tests, by Food Tested USD Million (2025-2030)
  • Table 225. Brazil Rapid Tests, by Contaminant USD Million (2025-2030)
  • Table 226. Argentina Rapid Tests, by Type USD Million (2025-2030)
  • Table 227. Argentina Rapid Tests, by Application USD Million (2025-2030)
  • Table 228. Argentina Rapid Tests, by Technology USD Million (2025-2030)
  • Table 229. Argentina Rapid Tests, by Food Tested USD Million (2025-2030)
  • Table 230. Argentina Rapid Tests, by Contaminant USD Million (2025-2030)
  • Table 231. Rest of South America Rapid Tests, by Type USD Million (2025-2030)
  • Table 232. Rest of South America Rapid Tests, by Application USD Million (2025-2030)
  • Table 233. Rest of South America Rapid Tests, by Technology USD Million (2025-2030)
  • Table 234. Rest of South America Rapid Tests, by Food Tested USD Million (2025-2030)
  • Table 235. Rest of South America Rapid Tests, by Contaminant USD Million (2025-2030)
  • Table 236. Asia Pacific Rapid Tests, by Country USD Million (2025-2030)
  • Table 237. Asia Pacific Rapid Tests, by Type USD Million (2025-2030)
  • Table 238. Asia Pacific Rapid Tests, by Application USD Million (2025-2030)
  • Table 239. Asia Pacific Rapid Tests, by Technology USD Million (2025-2030)
  • Table 240. Asia Pacific Rapid Tests, by Food Tested USD Million (2025-2030)
  • Table 241. Asia Pacific Rapid Tests, by Contaminant USD Million (2025-2030)
  • Table 242. China Rapid Tests, by Type USD Million (2025-2030)
  • Table 243. China Rapid Tests, by Application USD Million (2025-2030)
  • Table 244. China Rapid Tests, by Technology USD Million (2025-2030)
  • Table 245. China Rapid Tests, by Food Tested USD Million (2025-2030)
  • Table 246. China Rapid Tests, by Contaminant USD Million (2025-2030)
  • Table 247. Japan Rapid Tests, by Type USD Million (2025-2030)
  • Table 248. Japan Rapid Tests, by Application USD Million (2025-2030)
  • Table 249. Japan Rapid Tests, by Technology USD Million (2025-2030)
  • Table 250. Japan Rapid Tests, by Food Tested USD Million (2025-2030)
  • Table 251. Japan Rapid Tests, by Contaminant USD Million (2025-2030)
  • Table 252. India Rapid Tests, by Type USD Million (2025-2030)
  • Table 253. India Rapid Tests, by Application USD Million (2025-2030)
  • Table 254. India Rapid Tests, by Technology USD Million (2025-2030)
  • Table 255. India Rapid Tests, by Food Tested USD Million (2025-2030)
  • Table 256. India Rapid Tests, by Contaminant USD Million (2025-2030)
  • Table 257. South Korea Rapid Tests, by Type USD Million (2025-2030)
  • Table 258. South Korea Rapid Tests, by Application USD Million (2025-2030)
  • Table 259. South Korea Rapid Tests, by Technology USD Million (2025-2030)
  • Table 260. South Korea Rapid Tests, by Food Tested USD Million (2025-2030)
  • Table 261. South Korea Rapid Tests, by Contaminant USD Million (2025-2030)
  • Table 262. Taiwan Rapid Tests, by Type USD Million (2025-2030)
  • Table 263. Taiwan Rapid Tests, by Application USD Million (2025-2030)
  • Table 264. Taiwan Rapid Tests, by Technology USD Million (2025-2030)
  • Table 265. Taiwan Rapid Tests, by Food Tested USD Million (2025-2030)
  • Table 266. Taiwan Rapid Tests, by Contaminant USD Million (2025-2030)
  • Table 267. Australia Rapid Tests, by Type USD Million (2025-2030)
  • Table 268. Australia Rapid Tests, by Application USD Million (2025-2030)
  • Table 269. Australia Rapid Tests, by Technology USD Million (2025-2030)
  • Table 270. Australia Rapid Tests, by Food Tested USD Million (2025-2030)
  • Table 271. Australia Rapid Tests, by Contaminant USD Million (2025-2030)
  • Table 272. Rest of Asia-Pacific Rapid Tests, by Type USD Million (2025-2030)
  • Table 273. Rest of Asia-Pacific Rapid Tests, by Application USD Million (2025-2030)
  • Table 274. Rest of Asia-Pacific Rapid Tests, by Technology USD Million (2025-2030)
  • Table 275. Rest of Asia-Pacific Rapid Tests, by Food Tested USD Million (2025-2030)
  • Table 276. Rest of Asia-Pacific Rapid Tests, by Contaminant USD Million (2025-2030)
  • Table 277. Europe Rapid Tests, by Country USD Million (2025-2030)
  • Table 278. Europe Rapid Tests, by Type USD Million (2025-2030)
  • Table 279. Europe Rapid Tests, by Application USD Million (2025-2030)
  • Table 280. Europe Rapid Tests, by Technology USD Million (2025-2030)
  • Table 281. Europe Rapid Tests, by Food Tested USD Million (2025-2030)
  • Table 282. Europe Rapid Tests, by Contaminant USD Million (2025-2030)
  • Table 283. Germany Rapid Tests, by Type USD Million (2025-2030)
  • Table 284. Germany Rapid Tests, by Application USD Million (2025-2030)
  • Table 285. Germany Rapid Tests, by Technology USD Million (2025-2030)
  • Table 286. Germany Rapid Tests, by Food Tested USD Million (2025-2030)
  • Table 287. Germany Rapid Tests, by Contaminant USD Million (2025-2030)
  • Table 288. France Rapid Tests, by Type USD Million (2025-2030)
  • Table 289. France Rapid Tests, by Application USD Million (2025-2030)
  • Table 290. France Rapid Tests, by Technology USD Million (2025-2030)
  • Table 291. France Rapid Tests, by Food Tested USD Million (2025-2030)
  • Table 292. France Rapid Tests, by Contaminant USD Million (2025-2030)
  • Table 293. Italy Rapid Tests, by Type USD Million (2025-2030)
  • Table 294. Italy Rapid Tests, by Application USD Million (2025-2030)
  • Table 295. Italy Rapid Tests, by Technology USD Million (2025-2030)
  • Table 296. Italy Rapid Tests, by Food Tested USD Million (2025-2030)
  • Table 297. Italy Rapid Tests, by Contaminant USD Million (2025-2030)
  • Table 298. United Kingdom Rapid Tests, by Type USD Million (2025-2030)
  • Table 299. United Kingdom Rapid Tests, by Application USD Million (2025-2030)
  • Table 300. United Kingdom Rapid Tests, by Technology USD Million (2025-2030)
  • Table 301. United Kingdom Rapid Tests, by Food Tested USD Million (2025-2030)
  • Table 302. United Kingdom Rapid Tests, by Contaminant USD Million (2025-2030)
  • Table 303. Netherlands Rapid Tests, by Type USD Million (2025-2030)
  • Table 304. Netherlands Rapid Tests, by Application USD Million (2025-2030)
  • Table 305. Netherlands Rapid Tests, by Technology USD Million (2025-2030)
  • Table 306. Netherlands Rapid Tests, by Food Tested USD Million (2025-2030)
  • Table 307. Netherlands Rapid Tests, by Contaminant USD Million (2025-2030)
  • Table 308. Rest of Europe Rapid Tests, by Type USD Million (2025-2030)
  • Table 309. Rest of Europe Rapid Tests, by Application USD Million (2025-2030)
  • Table 310. Rest of Europe Rapid Tests, by Technology USD Million (2025-2030)
  • Table 311. Rest of Europe Rapid Tests, by Food Tested USD Million (2025-2030)
  • Table 312. Rest of Europe Rapid Tests, by Contaminant USD Million (2025-2030)
  • Table 313. MEA Rapid Tests, by Country USD Million (2025-2030)
  • Table 314. MEA Rapid Tests, by Type USD Million (2025-2030)
  • Table 315. MEA Rapid Tests, by Application USD Million (2025-2030)
  • Table 316. MEA Rapid Tests, by Technology USD Million (2025-2030)
  • Table 317. MEA Rapid Tests, by Food Tested USD Million (2025-2030)
  • Table 318. MEA Rapid Tests, by Contaminant USD Million (2025-2030)
  • Table 319. Middle East Rapid Tests, by Type USD Million (2025-2030)
  • Table 320. Middle East Rapid Tests, by Application USD Million (2025-2030)
  • Table 321. Middle East Rapid Tests, by Technology USD Million (2025-2030)
  • Table 322. Middle East Rapid Tests, by Food Tested USD Million (2025-2030)
  • Table 323. Middle East Rapid Tests, by Contaminant USD Million (2025-2030)
  • Table 324. Africa Rapid Tests, by Type USD Million (2025-2030)
  • Table 325. Africa Rapid Tests, by Application USD Million (2025-2030)
  • Table 326. Africa Rapid Tests, by Technology USD Million (2025-2030)
  • Table 327. Africa Rapid Tests, by Food Tested USD Million (2025-2030)
  • Table 328. Africa Rapid Tests, by Contaminant USD Million (2025-2030)
  • Table 329. North America Rapid Tests, by Country USD Million (2025-2030)
  • Table 330. North America Rapid Tests, by Type USD Million (2025-2030)
  • Table 331. North America Rapid Tests, by Application USD Million (2025-2030)
  • Table 332. North America Rapid Tests, by Technology USD Million (2025-2030)
  • Table 333. North America Rapid Tests, by Food Tested USD Million (2025-2030)
  • Table 334. North America Rapid Tests, by Contaminant USD Million (2025-2030)
  • Table 335. United States Rapid Tests, by Type USD Million (2025-2030)
  • Table 336. United States Rapid Tests, by Application USD Million (2025-2030)
  • Table 337. United States Rapid Tests, by Technology USD Million (2025-2030)
  • Table 338. United States Rapid Tests, by Food Tested USD Million (2025-2030)
  • Table 339. United States Rapid Tests, by Contaminant USD Million (2025-2030)
  • Table 340. Canada Rapid Tests, by Type USD Million (2025-2030)
  • Table 341. Canada Rapid Tests, by Application USD Million (2025-2030)
  • Table 342. Canada Rapid Tests, by Technology USD Million (2025-2030)
  • Table 343. Canada Rapid Tests, by Food Tested USD Million (2025-2030)
  • Table 344. Canada Rapid Tests, by Contaminant USD Million (2025-2030)
  • Table 345. Mexico Rapid Tests, by Type USD Million (2025-2030)
  • Table 346. Mexico Rapid Tests, by Application USD Million (2025-2030)
  • Table 347. Mexico Rapid Tests, by Technology USD Million (2025-2030)
  • Table 348. Mexico Rapid Tests, by Food Tested USD Million (2025-2030)
  • Table 349. Mexico Rapid Tests, by Contaminant USD Million (2025-2030)
  • Table 350. Rapid Tests: by Type(USD/Units)
  • Table 351. Research Programs/Design for This Report
  • Table 352. Key Data Information from Secondary Sources
  • Table 353. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Rapid Tests: by Type USD Million (2018-2023)
  • Figure 5. Global Rapid Tests: by Application USD Million (2018-2023)
  • Figure 6. Global Rapid Tests: by Technology USD Million (2018-2023)
  • Figure 7. Global Rapid Tests: by Food Tested USD Million (2018-2023)
  • Figure 8. Global Rapid Tests: by Contaminant USD Million (2018-2023)
  • Figure 9. South America Rapid Tests Share (%), by Country
  • Figure 10. Asia Pacific Rapid Tests Share (%), by Country
  • Figure 11. Europe Rapid Tests Share (%), by Country
  • Figure 12. MEA Rapid Tests Share (%), by Country
  • Figure 13. North America Rapid Tests Share (%), by Country
  • Figure 14. Global Rapid Tests: by Type USD/Units (2018-2023)
  • Figure 15. Global Rapid Tests share by Players 2023 (%)
  • Figure 16. Global Rapid Tests share by Players (Top 3) 2023(%)
  • Figure 17. Global Rapid Tests share by Players (Top 5) 2023(%)
  • Figure 18. BCG Matrix for key Companies
  • Figure 19. Akers Biosciences, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Akers Biosciences, Inc. (United States) Revenue: by Geography 2023
  • Figure 21. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 22. Abbott Laboratories (United States) Revenue: by Geography 2023
  • Figure 23. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 24. Becton, Dickinson and Company (United States) Revenue: by Geography 2023
  • Figure 25. Bio-rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Bio-rad Laboratories, Inc. (United States) Revenue: by Geography 2023
  • Figure 27. Cepheid, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Cepheid, Inc. (United States) Revenue: by Geography 2023
  • Figure 29. Hologic Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Hologic Inc. (United States) Revenue: by Geography 2023
  • Figure 31. Meridian Bioscience, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Meridian Bioscience, Inc. (United States) Revenue: by Geography 2023
  • Figure 33. OraSure Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. OraSure Technologies, Inc. (United States) Revenue: by Geography 2023
  • Figure 35. Quidel Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 36. Quidel Corporation (United States) Revenue: by Geography 2023
  • Figure 37. F. Hoffman La Roche, Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 38. F. Hoffman La Roche, Ltd. (Switzerland) Revenue: by Geography 2023
  • Figure 39. Global Rapid Tests: by Type USD Million (2025-2030)
  • Figure 40. Global Rapid Tests: by Application USD Million (2025-2030)
  • Figure 41. Global Rapid Tests: by Technology USD Million (2025-2030)
  • Figure 42. Global Rapid Tests: by Food Tested USD Million (2025-2030)
  • Figure 43. Global Rapid Tests: by Contaminant USD Million (2025-2030)
  • Figure 44. South America Rapid Tests Share (%), by Country
  • Figure 45. Asia Pacific Rapid Tests Share (%), by Country
  • Figure 46. Europe Rapid Tests Share (%), by Country
  • Figure 47. MEA Rapid Tests Share (%), by Country
  • Figure 48. North America Rapid Tests Share (%), by Country
  • Figure 49. Global Rapid Tests: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Akers Biosciences, Inc. (United States)
  • Abbott Laboratories (United States)
  • Becton, Dickinson and Company (United States)
  • Bio-rad Laboratories, Inc. (United States)
  • Cepheid, Inc. (United States)
  • Hologic Inc. (United States)
  • Meridian Bioscience, Inc. (United States)
  • OraSure Technologies, Inc. (United States)
  • Quidel Corporation (United States)
  • F. Hoffman La Roche, Ltd. (Switzerland)
Select User Access Type

Key Highlights of Report


Apr 2024 235 Pages 62 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Rapid Tests Quantitative research analysis
Global Rapid Tests Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Rapid Tests market are Akers Biosciences, Inc. (United States), Abbott Laboratories (United States), Becton, Dickinson and Company (United States), Bio-rad Laboratories, Inc. (United States), Cepheid, Inc. (United States), Hologic Inc. (United States), Meridian Bioscience, Inc. (United States), OraSure Technologies, Inc. (United States), Quidel Corporation (United States) and F. Hoffman La Roche, Ltd. (Switzerland), to name a few.
"Surge in R&D Activities" is seen as one of major influencing trends for Rapid Tests Market during projected period 2023-2030.
is dominating the Rapid Tests Market.
The Rapid Tests market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Rapid Tests Report?

Have a Query? Click Here

Other Related Reports

Virtual Reality (VR) in Healthcare Comprehensive Study by Application (Surgical Training, Surgical Navigation, Others), Components (Software System, Hardware Devices, Services), End Users (Hospitals,...
$ 3750
Mobile Health Vehicle Comprehensive Study by Type (Van, Truck, Trailer, Others), Application (Intensive Care, Dental Care, Blood Donation, Medical Imaging, Others) Players and Region - Global Market ...
$ 3500
Healthcare Facility Management Comprehensive Study by Type (Plumbing, Air Conditioning Maintenance, Fire Protection Systems, Mechanical and Electrical Maintenance, Cleaning and Pest Control, Laundry/...
$ 3800
Wound Debridement Comprehensive Study by Type (Gels, Ointments, Surgical devices, Medical gauzes, Ultrasonic devices, Others), Type of Wound (Acute Wound (Incision Wounds, Abrasion Wounds, Others), C...
$ 3750
Bamboo Leaf Extract Comprehensive Study by Application (Cosmetic, Health care, Chemical, Food, Nutraceuticals, Others), Type (Powder, Liquid), Channel (Direct channel, Indirect channel, Other), Mode ...
$ 3650
Dental Regenerative Comprehensive Study by Type (Dentin, Dental Pulp, Tooth Enamel), Material (Restorative Material, - Amalgam, - Resin Base Composite, - Glass Ionomer, - Resin Modified Glass Ionomer...
$ 3750